ClassID:

91542

C07C47/277 - CPC Classification

Classification description:

Compounds having —CHO groups; Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups

Recent Application in this class:
#1
20250376430
2025-12-11

DIFLUOROALDEHYDE, EPOXY, AND DERIVATIVE THEREOF

#2
20250236633
2025-07-24

SYNTHESIS OF ISOMERICALLY PURE POLYOL-BASED PHOSPHORAMIDITES

#3
20230126581
2023-04-27

Oxa-Sandalwood-Type Fragrance Compounds

#4
20230106081
2023-04-06

METHODS OF TREATING PARKINSON'S DISEASE

#5
20220276257
2022-09-01

Modular Chemical Probe For Detection Of Amino Acid Citrulline In Physiological Samples

#6
20220153765
2022-05-19

METHODS OF TREATING PARKINSON'S DISEASE

#7
20200262852
2020-08-20

Methods of treating Parkinson's disease

#8
20200247834
2020-08-06

Compounds and process for preparation of the same from cashew nut shell liquid (CNSL)

#9
20190375770
2019-12-12

Carbidopa prodrug

#10
20190367468
2019-12-05

Process for preparing (2E,6Z)-2,6-nonadienal and a process for preparing (2E)-cis 6,7-epoxy-2-nonenal

#11
20190292209
2019-09-26

Compounds and process for preparation of the same from cashew nut shell liquid (CNSL)

#12
20190218165
2019-07-18

Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases

#13
20190031697
2019-01-31

Phosphine substituted ferrocenyl complex

#14
20190031586
2019-01-31

Organic compound, three-dimensional organic framework formed by using organic compound, separation sieve and optical layer, which comprise organic framework, and optical device comprising optical layer as optical amplification layer

#15
20180327377
2018-11-15

Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same

#16
20180265442
2018-09-20

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

#17
20180079762
2018-03-22

Carbidopa and L-dopa prodrugs and methods of use

#18
20180037529
2018-02-08

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

#19
20160362389
2016-12-15

Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same

#20
20160289595
2016-10-06

Compound with a woody odour

#21
20160244392
2016-08-25

Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

#22
20160016880
2016-01-21

Bicyclo [2.2.1] acid GPR120 modulators

#23
20150203430
2015-07-23

Compounds from antrodia camphorate and their use in treatment of diabetes mellitus

#24
20150051294
2015-02-19

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

#25
20130331323
2013-12-12

GLP-1 potentiators from hedychium coronarium and their applications

#26
20120220792
2012-08-30

Process for producing aldehydes or ketones by oxidizing alcohols with oxygen

#27
20120041234
2012-02-16

Microwave induced single step green synthesis of some novel 2-aryl aldehydes and their analogues

#28
20110301365
2011-12-08

ALPHA-SUBSTITUTED ALPHA, BETA-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION ALPHA, BETA

#29
20110294171
2011-12-01

PREPARATION OF A SATURATED ALDEHYDE

#30
20110229426
2011-09-22

Perfuming ingredients of the floral and/or anis type

#31
20110166239
2011-07-07

2,3,3-Trimethylcyclopent-3-Enecarbaldehyde Derivatives Useful as Odorants

#32
20110124679
2011-05-26

2-substituted--quinone derivatives for treatment of oxidative stress diseases

#33
20110071178
2011-03-24

Methods and Compounds for Modulating Cannabinoid Activity

#34
20110039874
2011-02-17

MONOACYLGLYCEROL LIPASE INHIBITORS FOR MODULATION OF CANNABINOID ACTIVITY

#35
20110028746
2011-02-03

METHOD FOR THE DECARBOXYLATIVE HYDROFORMYLATION OF ALPHA, BETA- UNSATURATED CARBOXYLIC ACIDS

#36
20100292342
2010-11-18

Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof

#37
20100249075
2010-09-30

Substituted tetralins as selective estrogen receptor-β agonists

#38
20100234630
2010-09-16

Alpha-substituted α,β-unsaturated E- or Z-aldehydes, use thereof, and processes for their preparation α,β

#39
20100197972
2010-08-05

Preparation of a saturated aldehyde

#40
20100145060
2010-06-10

Schwartz reagents: methods of in situ generation and use

#41
20100130749
2010-05-27

Methods for the production of C-8 lactam lactone compounds

#42
20100105782
2010-04-29

2,3,3-Trimethylcyclopent-3-Enecarbaldehyde Derivatives Useful as Odorants

#43
20100063075
2010-03-11

Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives

#44
20100055168
2010-03-04

CATIONIC LIPIDS AND USES THEREOF

#45
20100009976
2010-01-14

Benzothiazin-3-one compound and intermediate therefor

#46
20090312315
2009-12-17

PAI-1 inhibitor

#47
20090306016
2009-12-10

Fatty acid amide hydrolase inhibitors

#48
20090285881
2009-11-19

CATIONIC LIPIDS AND USES THEREOF

#49
20090259073
2009-10-15

Method for producing aldehyde using bisphosphite and group 8-10 metal compound, and such bisphosphite

#50
20090227801
2009-09-10

LIGANDS FOR USE IN ASYMMETRIC HYDROFORMYLATION

#51
20090182174
2009-07-16

Method for hydrogenation of α, β-unsaturated carbonyl compounds

#52
20090176999
2009-07-09

Process for producing hexahydrofurofuranol derivative

#53
20090018332
2009-01-15

Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors

#54
20080287441
2008-11-20

ALPHA-(TRIFLUOROMETHYL-SUBSTITUTED ARYLOXY, ARYLAMINO, ARYLTHIO OR ARYLMETHYL)-TRIFLUOROMETHYL-SUBSTITUTED PHENYLACETIC ACIDS AND DERIVATIVES AS ANTIDIABETIC AGENTS

#55
20080188557
2008-08-07

Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof

#56
20080125310
2008-05-29

Hydride reduction of alpha, beta-unsaturated carbonyl compounds using chiral organic catalysts

#57
20080058321
2008-03-06

Benzothiazin-3-one compound and intermediate therefor

#58
20080007840
2008-01-10

Optical apparatus and methods for chemical analysis

#59
20070292540
2007-12-20

Extracts and Methods Comprising Cinnamon Species

#60
20070276142
2007-11-29

Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl Compounds

#61
20070254959
2007-11-01

Process for obtaining tolterodine

#62
20070244344
2007-10-18

Method for producing 2,7-dimethyl-octa-2,4,6-trienedial

#63
20070225261
2007-09-27

Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

#64
20070197836
2007-08-23

Method for producing halogenated unsaturated carbonyl compound

#65
20070191643
2007-08-16

Process for producing cyclopropane monoacetal derivative and intermediate therefor

#66
20060257330
2006-11-16

Powdery pharmaceutical compositions for inhalation

#67
20060235073
2006-10-19

Diamino-functional chalcones

#68
20060161024
2006-07-20

Hydride reduction of α,β-unsaturated carbonyl compounds using chiral organic catalysts

#69
20060079685
2006-04-13

Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives

#70
20060052600
2006-03-09

Amino-functional chalcones

#71
20060052277
2006-03-09

Aliphatic compounds as fragrants with musk characteristics

#72
20050245759
2005-11-03

Process for producing cinnamaldehyde derivatives, use thereof and the like

#73
20050227990
2005-10-13

Aminoalkoxy-functional chalcones

#74
20050222213
2005-10-06

α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents

#75
20050027013
2005-02-03

LTAhydrolase inhibitors

#76
20050014972
2005-01-20

Novel intermediate for sweetener with high sweetness and process for producing the same